Ann Knoop - Dissemin

Papers authored by Ann Knoop

This paper is made freely available by the publisher.

2009 B. Ejlertsen, M. B. Jensen, Kv Nielsen, E. Balslev, Gl L. Willemoe, Pb B. Hertel, As S. Knoop

, Ht T. Mouridsen, N. Bruenner, N. Brünner

TOP2A , TIMP-1 and responsiveness to adjuvant anthracycline containing chemotherapy in high risk breast cancer patients.

Download from aacrjournals.org

This paper is available in a repository.

2008 Kirsten Vang Nielsen, Bent Ejlertsen, Susanne Møller, Jan Trøst Jørgensen, Ann Knoop

, Helle Knudsen, Henning T. Mouridsen

The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D

Download from www.researchgate.net

This paper was not found in any repository, but could be made available legally by the author.

2007 Anne Roslind, Ann S. Knoop

, Maj-Britt Jensen, Julia S. Johansen, Dorte L. Nielsen, Paul A. Price, Eva Balslev

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Ann Søegaard Knoop

, Knoop As, Birgitte Bruun Rasmussen, Rasmussen Bb

[Prognostic and predictive factors for endocrine treatment in breast carcinoma].

Upload

Anette Damkier, Christine Paludan Müller, Knoop As, Ann Søegaard Knoop

[Use of complementary and alternative medicine (CAM) in breast cancer patients. Efficacy and interactions].

Upload

M. B. Petersen, A. Laenkholm, N. Pallisgaard, W. Vach, A. Knoop

, M. Bak, H. J. Ditzel

Intratumoral genetic heterogeneity of breast carcinomas

Upload

Distributing this paper is prohibited by the publisher

Birgitte Vrou Offersen, Birgitte Vrou Offersen, Offersen Bv, Rikke Riisbro, Ann Knoop

, Nils Brünner, Jens Overgaard, Danish Breast Cancer Cooperative Group (DBCG) Tumor Biology Committee

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer

Upload

A. Roslind, A. S. Knoop

, M.-B. Jensen, J. S. Johansen, D. L. Nielsen, P. A. Price, E. Balslev

Immunohistochemical expression of YKL-40 is not a prognostic marker in patients with high-risk primary breast cancer

Upload

Maria B. Lyng, Lyng Mb, Laenkholm Av, Anne-Vibeke Lænkholm, Niels Pallisgaard, Werner Vach, Ann Knoop

, Martin Bak, Henrik J. Ditzel, Ditzel Hj

Intratumor Genetic Heterogeneity of Breast Carcinomas as Determined by Fine Needle Aspiration and TaqMan Low Density Array

Download from doaj.org

A. S. Knoop

, B. B. Rasmussen

Prognostic and predictive factors for endocrine treatment in breast carcinoma,Status over klinisk anvendte prognostiske og prædiktive faktorer ved allokering til systemisk behandling efter primær cancer mammae

Upload

A. Damkier, C. Paludan-Müller, A. S. Knoop

Use of complementary and alternative medicine (CAM) in breast cancer patients - Efficacy and interactions,Brystkræftpatienters brug af komplementær og alternativ medicin - Effekt og interaktioner

Upload

M. B. Lyng, A. Laenkholm, W. Vach, N. Pallisgaard, A. Knoop

, H. J. Ditzel

Predictive gene expression profile of breast cancer patients treated with tamoxifen

Upload

2006 K. Gunnarsdottir, M.-B. Jensen, D. Zahrieh, R. Gelber, A. Knoop

, M. Bonetti, H. Mouridsen, B. Ejlertsen

CEF is superior to CMF for tumors with topoisomerase II alpha gene alterations: a STEPP (subpopulation treatment effect pattern plot) analysis on Danish breast cancer cooperative group study 89D

Upload

2005 Ann S. Knoop

, Helle Knudsen, Eva Balslev, Birgitte B. Rasmussen, Jens Overgaard, Kirsten V. Nielsen, Andreas Schonau, Katrín Gunnarsdóttir, Karen E. Olsen, Henning Mouridsen, Bent Ejlertsen

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Download from doi.org

S. Cold, R. P. Panikkar, M. Düring, M. Ewertz, L. J. Goldstein, S. Møller, Ann Knoop

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

Download from doi.org

B. Offersen, R. Riisbro, A. Knoop

, N. Brunner, J. Overcaard

The prognostic influence of Plasminogen Activator Inhibitor-1 in early breast cancer is not related to estimates of angiogenesis

Upload

2004 Karen E. Olsen, Olsen Ke, Helle Knudsen, Birgitte B. Rasmussen, Rasmussen Bb, Eva Balslev, Ann Knoop

, Kirsten V. Nielsen, Bent Ejlertsen, Andreas Schönau, Nielsen Kv, Jens Overgaard, Danish Breast Cancer Co-Operative Group

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

Download from www.researchgate.net

2003 M. K. Heatley, C. Whiteside, P. G. Toner, B. V. Offersen, P. Maxwell, F. B. Sørensen

, Ann Knoop

, P. Ewing, J. Overgaard

The prognostic relevance of estimates of proliferative activity in early breast cancer

Upload

S. Hansen, J. Overgaard, C. Rose, A.-V. Lænkholm, Ann Knoop

, J. Andersen, F. B. Sørensen

, P. A. Andreasen

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

Download from www.nature.com

2002 Birgitte V. Offersen, Flemming Brandt Sørensen

, Mette Yilmaz, Ann Knoop

, Jens Overgaard, Danish Breast Cancer Cooperative Group Tumour Biology Committee

Chalkley Estimates of Angiogenesis in Early Breast Cancer - Relevance to Prognosis

Download from www.tandfonline.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Ann Knoop